🎤 Invst Guru Founder Series 🎤

In this episode of Invst Guru, host Jeff “Fuzzy” Wenzel sits down with Mitch Raponi, CEO and Co-Founder of Emerrx BioPharma, to discuss how his company is tackling one of the biggest public health challenges of our time — the opioid overdose crisis.

Mitch reveals how Emerrx’s breakthrough drug-device platform, MRX-101, is transforming naloxone delivery with faster, more effective absorption, potentially saving thousands of lives. From the science behind the innovation to Emerrx’s crowdfunding campaign on MicroVentures, this conversation dives deep into biotech entrepreneurship, impact investing, and the future of emergency medicine.

In this episode, you’ll learn:

• Why current overdose rescue products like Narcan aren’t as effective as we think

• How Emerrx’s dual-chamber delivery system mimics IV-level absorption

• The company’s capital-efficient startup strategy and upcoming milestones

• What biotech investors can expect from early-stage medical innovation

🔗 Learn more:
Visit mrx.com or check out Emerrx on MicroVentures.com

🎙️ About the Show:
Invst Guru, hosted by Jeff “Fuzzy” Wenzel, features startup founders and entrepreneurs shaping the future of innovation, investment, and impact.

“Disclaimer: This content is provided for informational and educational purposes only and should not be construed as investment advice or a solicitation to invest. Invst Guru and its affiliates are not broker-dealers or investment advisers and do not make recommendations regarding any securities.

If any company mentioned is conducting a Regulation Crowdfunding (Reg CF) raise, all investments must occur through an SEC-registered intermediary platform such as DealMaker Securities, StartEngine, Republic, or Wefunder. No investment terms or returns are discussed here.

Investing in private and early-stage companies involves significant risk, including loss of capital and illiquidity. Past performance is not indicative of future results. Always conduct your own due diligence and consult a licensed financial advisor before investing.

All opinions expressed by guests are their own and do not represent endorsements or partnerships by Invst Guru.”